Evaluation of Vision Effects of a Cosmetic Tinted Hydrogel Contact Lens

Inclusion criteria

• The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
• The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
• The subject must be between 35 and 42 years of age (inclusive).
• The subject's vertex corrected spherical equivalent distance refraction must be in the range of -6.00 Diopters (D) to +4.00 D in each eye.
• The subject's refractive cylinder must be ≤ 0.75 D in each eye.
• The subject must have best corrected visual acuity of 20/30 or better in each eye.
• The subject must be an adapted soft contact lens wearer in both eyes (defined as a minimum of 6 hours of Daily Wear (DW) for a minimum of 1 month prior to the study).
• The subject must have normal eyes (i.e., no ocular medications or infections of any type).

Exclusion criteria

• Currently pregnant or lactating (subjects who become pregnant during the study will be discontinued).
• Any ocular or systemic allergies or diseases that may interfere with contact lens wear.
• Any infectious disease (e.g., hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g., HIV) by self-report.
• Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining, or any other abnormalities of the cornea which would contraindicate contact lens wear.
• Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection which might interfere with contact lens wear.
• Any ocular infection.
• Any previous, or planned, ocular or interocular surgery (e.g., radial keratotomy, photorefractive keratectomy (PRK), laser-assisted in situ keratomileusis (LASIK), etc.)
• Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
• Habitual contact lens type is toric, bifocal, in monovision contact lens wear, or is worn as extended wear.
• Participation in any contact lens or lens care product clinical trial within 30 days prior to study enrollment.
• Employee of investigational clinic (e.g., Investigator, Coordinator, Technician)